Page:United States Statutes at Large Volume 117.djvu/2156

From Wikisource
Jump to navigation Jump to search
This page needs to be proofread.

[117 STAT. 2137]
PUBLIC LAW 107-000—MMMM. DD, 2003
[117 STAT. 2137]

PUBLIC LAW 108–173—DEC. 8, 2003

117 STAT. 2137

‘‘(A) IN GENERAL.—Each prescription drug card sponsor that offers an endorsed discount card program shall make available to discount card eligible individuals (through the Internet and otherwise) information that the Secretary identifies as being necessary to promote informed choice among endorsed discount card programs by such individuals, including information on enrollment fees and negotiated prices for covered discount card drugs charged to such individuals. ‘‘(B) RESPONSE TO ENROLLEE QUESTIONS.—Each sponsor offering an endorsed discount card program shall have a mechanism (including a toll-free telephone number) for providing upon request specific information (such as negotiated prices and the amount of transitional assistance remaining available through the program) to discount card eligible individuals enrolled in the program. The sponsor shall inform transitional assistance eligible individuals enrolled in the program of the availability of such tollfree telephone number to provide information on the amount of available transitional assistance. ‘‘(C) INFORMATION ON BALANCE OF TRANSITIONAL ASSISTANCE AVAILABLE AT POINT-OF-SALE.—Each sponsor offering an endorsed discount card program shall have a mechanism so that information on the amount of transitional assistance remaining under subsection (g)(1)(B) is available (electronically or by telephone) at the point-ofsale of covered discount card drugs. ‘‘(3) PUBLIC DISCLOSURE OF PHARMACEUTICAL PRICES FOR EQUIVALENT DRUGS.— ‘‘(A) IN GENERAL.—A prescription drug card sponsor offering an endorsed discount card program shall provide that each pharmacy that dispenses a covered discount card drug shall inform a discount card eligible individual enrolled in the program of any differential between the price of the drug to the enrollee and the price of the lowest priced generic covered discount card drug under the program that is therapeutically equivalent and bioequivalent and available at such pharmacy. ‘‘(B) TIMING OF NOTICE.— ‘‘(i) IN GENERAL.—Subject to clause (ii), the information under subparagraph (A) shall be provided at the time of purchase of the drug involved, or, in the case of dispensing by mail order, at the time of delivery of such drug. ‘‘(ii) WAIVER.—The Secretary may waive clause (i) in such circumstances as the Secretary may specify. ‘‘(e) DISCOUNT CARD FEATURES.— ‘‘(1) SAVINGS TO ENROLLEES THROUGH NEGOTIATED PRICES.— ‘‘(A) ACCESS TO NEGOTIATED PRICES.— ‘‘(i) IN GENERAL.—Each prescription drug card sponsor that offers an endorsed discount card program shall provide each discount card eligible individual enrolled in the program with access to negotiated prices.

VerDate 11-MAY-2000

13:59 Aug 30, 2004

Jkt 019194

PO 00000

Frm 00073

Fmt 6580

Sfmt 6581

D:\STATUTES\2003\19194PT3.001

APPS10

PsN: 19194PT3